Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00339 |
| Species: | Homo sapiens |
| Position : | chr2:60722300-60722700 |
| Year: | 2015 |
| Title: | BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 26375006 |
| MONDO: | |
| Tissue: | Hematopoietic system |
| Tissue Ontology ID: | UBERON:0002371 |
| Cell Source: | HUDEP-2 |
| CVCL ID: | CVCL_VI06 |
| Cell Type: | erythroid progenitor cell |
| Cell Ontology ID: | CL:0000038 |
| Experiment Type: | Functional perturbation assay, Enhancer activity assay |
| High Throughput Method: | ChIP-seq, RNA-seq, ATAC-seq |
| Low Throughput Method: | Luciferase Reporter Assay, CRISPR Knockout, ChIP-RT-qPCR |
| Target gene : | BCL11A |
| TF name : | GATA1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| GATA1 | C-MYB transcription factor network | pid | 87 |
| GATA1 | Factors involved in megakaryocyte development and platelet production | reactome | 111 |
| GATA1 | IL3 | netpath | 84 |
| GATA1 | Notch-mediated HES/HEY network | pid | 48 |
| GATA1 | p73 transcription factor network | pid | 80 |
| GATA1 | Signaling events mediated by HDAC Class I | pid | 89 |
| GATA1 | Signaling events mediated by HDAC Class II | pid | 58 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01052 | chr2:60718043-60725451 | Colon | colorectal carcinoma cell | colorectal carcinoma |